[HTML][HTML] SERS liquid biopsy profiling of serum for the diagnosis of kidney cancer
T Moisoiu, SD Iancu, D Burghelea, MP Dragomir… - Biomedicines, 2022 - mdpi.com
Renal cancer (RC) represents 3% of all cancers, with a 2% annual increase in incidence
worldwide, opening the discussion about the need for screening. However, no established …
worldwide, opening the discussion about the need for screening. However, no established …
[PDF][PDF] SERS Liquid Biopsy Profiling of Serum for the Diagnosis of Kidney Cancer. Biomedicines 2022, 10, 233
T Moisoiu, SD Iancu, D Burghelea, MP Dragomir… - 2022 - academia.edu
Renal cancer (RC) represents 3% of all cancers, with a 2% annual increase in incidence
worldwide, opening the discussion about the need for screening. However, no established …
worldwide, opening the discussion about the need for screening. However, no established …
SERS Liquid Biopsy Profiling of Serum for the Diagnosis of Kidney Cancer.
T Moisoiu, SD Iancu, D Burghelea… - …, 2022 - search.ebscohost.com
Abstract Renal cancer (RC) represents 3% of all cancers, with a 2% annual increase in
incidence worldwide, opening the discussion about the need for screening. However, no …
incidence worldwide, opening the discussion about the need for screening. However, no …
SERS Liquid Biopsy Profiling of Serum for the Diagnosis of Kidney Cancer.
T Moisoiu, SD Iancu, D Burghelea, MP Dragomir… - Biomedicines, 2022 - europepmc.org
Abstract Renal cancer (RC) represents 3% of all cancers, with a 2% annual increase in
incidence worldwide, opening the discussion about the need for screening. However, no …
incidence worldwide, opening the discussion about the need for screening. However, no …
SERS Liquid Biopsy Profiling of Serum for the Diagnosis of Kidney Cancer
T Moisoiu, SD Iancu, D Burghelea… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Renal cancer (RC) represents 3% of all cancers, with a 2% annual increase in incidence
worldwide, opening the discussion about the need for screening. However, no established …
worldwide, opening the discussion about the need for screening. However, no established …
[HTML][HTML] SERS Liquid Biopsy Profiling of Serum for the Diagnosis of Kidney Cancer
T Moisoiu, SD Iancu, D Burghelea, MP Dragomir… - …, 2022 - ncbi.nlm.nih.gov
Abstract Renal cancer (RC) represents 3% of all cancers, with a 2% annual increase in
incidence worldwide, opening the discussion about the need for screening. However, no …
incidence worldwide, opening the discussion about the need for screening. However, no …
SERS Liquid Biopsy Profiling of Serum for the Diagnosis of Kidney Cancer
T Moisoiu, SD Iancu, D Burghelea, MP Dragomir… - …, 2022 - search.proquest.com
Abstract Renal cancer (RC) represents 3% of all cancers, with a 2% annual increase in
incidence worldwide, opening the discussion about the need for screening. However, no …
incidence worldwide, opening the discussion about the need for screening. However, no …
SERS Liquid Biopsy Profiling of Serum for the Diagnosis of Kidney Cancer
T Moisoiu, SD Iancu, D Burghelea, MP Dragomir… - 2022 - agris.fao.org
Renal cancer (RC) represents 3% of all cancers, with a 2% annual increase in incidence
worldwide, opening the discussion about the need for screening. However, no established …
worldwide, opening the discussion about the need for screening. However, no established …
SERS Liquid Biopsy Profiling of Serum for the Diagnosis of Kidney Cancer.
T Moisoiu, SD Iancu, D Burghelea, MP Dragomir… - Biomedicines, 2022 - europepmc.org
Abstract Renal cancer (RC) represents 3% of all cancers, with a 2% annual increase in
incidence worldwide, opening the discussion about the need for screening. However, no …
incidence worldwide, opening the discussion about the need for screening. However, no …